$XBI $122 +3%
Covid Updates
$AZN +1% AZD7442 PROVENT Phase III prophylaxis trial met primary endpoint in preventing COVID-19. source
Pipeline Updates
$PSTV +1% PLUS THERAPEUTICS ANNOUNCES PRESENTATION OF DATA FROM THE RESPECT™-GBM TRIAL AND PLANS FOR TREATING PEDIATRIC BRAIN CANCER. source
$AZN +1% Update on CHAMPION-ALS Phase III trial of Ultomiris in amyotrophic lateral sclerosis. source
Financial Updates
$AGRX +5% AGILE THERAPEUTICS PARTNERS WITH TELEHEALTH SERVICE, PANDIA HEALTH, TO INCREASE WOMEN’S ACCESS TO TWIRLA® (LEVONORGESTREL AND ETHINYL ESTRADIOL) TRANSDERMAL SYSTEM. source
$PROG -55% Progenity Announces Pricing of $40 Million Public Offering of Common Stock and Warrants. source
Posted by DV
Comments